COMMUNIQUÉS West-GlobeNewswire

Meridian Bioscience Announces Preliminary Second Quarter 2019 Revenue Results; Updates Fiscal 2019 Guidance

02/04/2019 - 12:59

CINCINNATI, April 02, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today provided a business update including preliminary [...]

LHC Group and Geisinger finalize joint venture agreement for home health and hospice services in Pennsylvania

02/04/2019 - 12:30

LAFAYETTE, La. and DANVILLE, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) and Geisinger Home Health and Hospice finalized a previously announced joint venture partnership to enhance home health [...]

MannKind to Present at the H.C. Wainwright Global Life Sciences Conference

02/04/2019 - 12:00

WESTLAKE VILLAGE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases [...]

The Ensign Group Acquires Arizona Skilled Nursing Facility

02/04/2019 - 12:00

MISSION VIEJO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]

The Ensign Group Acquires Texas Memory Care Community

02/04/2019 - 12:00

MISSION VIEJO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]

Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti™ NDA

02/04/2019 - 12:00

SOLANA BEACH, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has [...]

Philips presents results from 3-year telehealth program impacting over 100,000 patients across Europe

02/04/2019 - 10:01

April 2, 2019 Advancing Care Coordination & Telehealth Deployment at Scale ( ACT@Scale ) Handbook now available to implement and grow population health management to improve patient care and reduce costs in an aging [...]

Lexington Biosciences Provides Update on Financial Situation

02/04/2019 - 10:00

VANCOUVER, British Columbia, April 02, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announced on February 14, 2019 that it had been unable to secure the [...]

Community Health Network decides for C-RAD’s innovative SIGRT solution

02/04/2019 - 09:15

C-RAD and Community Health Network announced today an agreement to equip three of their cancer centers located in the state of Indiana with C-RAD’s surface tracking solution based on Catalyst and Sentinel 4DCT. [...]

LIDDS announces a novel TLR9 agonist project and plan for Phase I clinical trial

02/04/2019 - 08:40

Clinical data shows that intratumoral delivery of TLR agonists in combination with immune checkpoint inhibitors can effectively treat solid cancers. NanoZolid® technology is very suitable to provide sustained [...]

Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance

02/04/2019 - 08:04

Knowledge base of antimicrobial resistance (AMR) markers tailored specifically to Unyvero Applications Developed by Curetis’ subsidiary Ares Genetics and powered by ARESdb Initial focus on Unyvero Pneumonia Applications [...]

Novartis first-in-class Cosentyx® approved in China for psoriasis patients

02/04/2019 - 07:16

China Health Authority NMPA approved Cosentyx ® (secukinumab) for moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy Cosentyx is the first biologic approved in [...]

FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin

02/04/2019 - 02:09

Approved for Use in the Treatment of Primary Humoral Immunodeficiency Disease (“PIDD” or “PI”) in Adults and Adolescents (12 to 17 Years of Age) FDA Approval Triggers Funding up to $27.5M from Existing Credit Facility [...]

MediciNova Announces Results of Subgroup Analysis from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS

02/04/2019 - 01:00

LA JOLLA, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]

BriaCell Announces Closing of Upsized & Oversubscribed Non-Brokered Private Placement of $2.97 Million

02/04/2019 - 00:45

BERKELEY, Calif., and VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]

Akers Biosciences Reports Fiscal Year 2018 Earnings

01/04/2019 - 23:31

Ongoing Measures to Streamline Operations, Reduce Costs and Position the Company for Strategic Alternatives THOROFARE, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the [...]

Hemispherx Reports 2018 Year-end Financial Results

01/04/2019 - 23:30

OCALA, Fla., April 01, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announces financial results for the fiscal year ended December 31, 2018, and provides a business update. Highlights of 2018 [...]

Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

01/04/2019 - 23:17

EMERYVILLE, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has issued inducement awards to five new [...]

DBV Technologies Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F

01/04/2019 - 23:00

Montrouge, France, April 1, 2019 DBV Technologies Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) [...]